gamma-linolenic-acid and Nephrotic-Syndrome

gamma-linolenic-acid has been researched along with Nephrotic-Syndrome* in 2 studies

Trials

1 trial(s) available for gamma-linolenic-acid and Nephrotic-Syndrome

ArticleYear
Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome.
    Journal of medicinal food, 2002,Summer, Volume: 5, Issue:2

    In nephrotic syndrome, large amounts of plasma proteins are lost in urine, causing a decrease in the plasma oncotic pressure. This leads to enhanced hepatic synthesis of albumin and other proteins, including lipoproteins, causing a secondary hyperlipidemia. Essential fatty acids such as gamma-linolenic acid (GLA) can prevent accumulation of cholesterol in the body, and spirulina has an appreciable amount of GLA. In this study 23 patients (age 2 to 13 years) with nephrotic syndrome received either medication (group I) or medication plus 1 g/day Spirulina (group II). Height, weight, and serum levels of fasting blood sugar, triglycerides, total cholesterol (TC), and low- and high-density cholesterol fractions (LDL-C and HDL-C, respectively) were measured before and after the 2-month study period. Mean height and weight were normal compared with healthy, age-matched Indian children. Lipoprotein cholesterol levels were significantly increased at baseline. TC significantly decreased by 116.33 mg/dl, LDL-C by 94.14 mg/dl, and triglycerides by 67.72 mg/dl in group II; in control group I, these values fell by 69.87, 61.13, and 22.62 mg/dl, respectively. The LDL-C:HDL-C ratio also decreased significantly, by 1.66 in group II and 1.13 in group I. TC:HDL-C decreased by 1.96 in group II and 1.19 in group I. HDL-C:LDL-C also improved significantly in both the groups. It can be concluded that spray-dried Spirulina capsules, rich in antioxidants, GLA, amino acids, and fatty acids, helped reduce the increased levels of lipids in patients with hyperlipidemic nephrotic syndrome.

    Topics: Adolescent; Anticholesteremic Agents; Bacterial Proteins; Body Height; Body Weight; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; gamma-Linolenic Acid; Humans; Hyperlipidemias; Male; Nephrotic Syndrome; Spirulina; Triglycerides

2002

Other Studies

1 other study(ies) available for gamma-linolenic-acid and Nephrotic-Syndrome

ArticleYear
A diet containing n-3 and n-6 fatty acids favorably alters the renal phospholipids, eicosanoid synthesis and plasma lipids in nephrotic rats.
    Lipids, 1988, Volume: 23, Issue:11

    The nephrotic syndrome was induced in rats by intravenous adriamycin (3 mg/kg). The rats were then divided into four groups which, for six weeks, were pair-fed diets containing beef tallow (BT), fish oil (FO), a source of n-3 fatty acids, evening primrose oil (EPO), a source of n-6 fatty acids, or a combination of evening primrose oil and fish oil, 75:25 (EPO:FO). The fat content of the diets was 15%. Significant incorporation of the fatty acids into kidney phospholipids was demonstrated. Diets containing FO, EPO and EPO:FO lowered plasma triglycerides and total cholesterol levels as compared with diets containing BT. Only EPO:FO raised high density lipoprotein (HDL) cholesterol levels, as compared with BT. The combination EPO:FO prevented the tenfold suppression of aortic 6-keto-PGF1 alpha caused by FO. These changes in plasma lipids and eicosanoid production are potentially antiatherogenic and may prevent glomerular sclerosis. The combination of EPO and FO, containing n-6 and n-3 fatty acids may offer advantages over either family of fatty acids in this model of nephrotic syndrome.

    Topics: Animals; Dietary Fats, Unsaturated; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Fish Oils; gamma-Linolenic Acid; Kidney; Linoleic Acids; Lipids; Nephrotic Syndrome; Oenothera biennis; Phospholipids; Plant Oils; Rats; Rats, Inbred Strains

1988